The Effect of Exercise Intervention on the Community's Older Adults
11 de maio de 2018 atualizado por: Robert Wen-Wei Hsu, Chang Gung Memorial Hospital
The Effect of Exercise Intervention on the Physical Fitness, Bone Mineral Density and Health-related Quality of Life in the Community's Older Adults
Osteoporosis is a serious global health problem, second only to cardiovascular disease.
Osteoporosis is the most common metabolic bone disease in the elderly population, characterized by loss of bone mineral density (BMD) and continuous destruction of bone microstructure, especially in postmenopausal women.
It gives rise to bone fragility and fracture risk.
Moreover, as people grow older, falls frequently occur with high severity, and nearly 35% to 45% of persons aged 65 or older fall at least once a year.
Osteoporotic fractures increase mortality, morbidity, chronic pain, and the cost of social care and it decreases the quality of life.
Here, investigators plan to perform different exercise interventions such as circuit exercise, aerobic dance and Tai Chi on the community's older adults to evaluate whether exercise intervention could improve the bone mineral density, physical fitness, muscle strength or quality of life.
Visão geral do estudo
Tipo de estudo
Intervencional
Inscrição (Real)
411
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
-
Pizi, Taiwan, 613
- Sports Medicine Center, Chang Gung Memorial Hospital
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
45 anos a 85 anos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- Being >45 years-of-age,
- Healthy and physically independent.
Exclusion Criteria:
- The exclusion criteria were individuals on hormone replacement therapy and those with cognitive impairment, progressive debilitating conditions, bone fractures, or any medical contraindications to administering the fitness assessment.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Ciência básica
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Control
without exercise intervention
|
|
|
Experimental: Exercise
Subjects with circuit exercise, aerobic dance, or Tai Chi exercise intervention.
|
circuit exercise, aerobic dance and Tai Chi exercise
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change from baseline bone mineral density
Prazo: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Bone mineral density measurement is measured by dual-energy x-ray absorptiometry (DXA).
Measurements are made over the lumbar spine and over the upper part of the hip and the measurement is assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change from baseline elbow muscle strength
Prazo: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of elbow were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Change from baseline shoulder muscle strength
Prazo: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of shoulder were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Change from baseline hip muscle strength
Prazo: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of hip were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Change from baseline knee muscle strength
Prazo: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of knee were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Change from baseline SF-36 questionnaire assessment
Prazo: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower score the more disability.
The higher the score the less disability.
Eight sections including physical function, role limitation due to physical problems, bodily pain, general health, vitality, social functioning, role limitation due to emotional problems, and mental health.
Additionally, the eight health domains can be used to provide a physical component summary and mental component summary score.
The outcome measurement is assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
High-density lipoprotein from blood sample
Prazo: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
High-density lipoprotein are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Triglyceride from blood sample
Prazo: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Triglyceride are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Fasting blood glucose from blood sample
Prazo: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Fasting blood glucose are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Blood pressure
Prazo: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Diastolic and systolic blood pressure are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Weight parameters of the subjects
Prazo: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Weight (kg) are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Height parameters of the subjects
Prazo: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Height (cm) are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Waistline parameters of the subjects
Prazo: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Waistline (cm) are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Robert Wen-Wei HSU, MD, Sports Medicine Center, Chang Gung Memorial Hospital, Chiayi
Publicações e links úteis
A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo
1 de novembro de 2009
Conclusão Primária (Real)
1 de dezembro de 2013
Conclusão do estudo (Real)
1 de dezembro de 2013
Datas de inscrição no estudo
Enviado pela primeira vez
13 de outubro de 2016
Enviado pela primeira vez que atendeu aos critérios de CQ
14 de outubro de 2016
Primeira postagem (Estimativa)
18 de outubro de 2016
Atualizações de registro de estudo
Última Atualização Postada (Real)
14 de maio de 2018
Última atualização enviada que atendeu aos critérios de controle de qualidade
11 de maio de 2018
Última verificação
1 de maio de 2018
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- CMRPG690111-3;CMRPG6A0421-22
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
INDECISO
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .